NAGA and cancer: Though the effect of GcMAF has been proven in the treatment of prognosis for patients with cancer and the concentration of nagalase (α-GalNAc-ase) in the patient’s blood has been used as a marker for cancer healing [14], no significant difference in the amounts of Gc protein-carrying trisaccharide in serum between healthy controls and patients with cancer has been reported [15].